Predicted protein targets (top 9)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | FBP1 | P09467 | 1/20 | 0.56 |
| ▸ | P2RY2 | P41231 | 11/20 | 0.54 |
| ▸ | P2RY4 | P51582 | 3/20 | 0.54 |
| ▸ | P2RY14 | Q15391 | 4/20 | 0.52 |
| ▸ | MACROD2 | A1Z1Q3 | 1/20 | 0.50 |
| ▸ | SIRT6 | Q8N6T7 | 1/20 | 0.50 |
| ▸ | MACROD1 | Q9BQ69 | 1/20 | 0.50 |
| ▸ | TRPM2 | O94759 | 1/20 | 0.50 |
| ▸ | AMDHD2 | Q9Y303 | 1/20 | 0.48 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL30748277 | 1.00 | FBP1 (0.56) | FBP1P2RY2P2RY4P2RY14MACROD2 | |
| SCHEMBL3411522 | 1.00 | FBP1 (0.56) | FBP1P2RY2P2RY4P2RY14MACROD2 | |
| SCHEMBL5063689 | 0.98 | FBP1 (0.54) | FBP1P2RY2P2RY4P2RY14MACROD2 | |
| SCHEMBL5063695 | 0.98 | FBP1 (0.54) | FBP1P2RY2P2RY4P2RY14MACROD2 | |
| SCHEMBL23723111 | 0.97 | FBP1 (0.59) | FBP1P2RY2P2RY4P2RY14MACROD2 | |
| SCHEMBL31540137 | 0.97 | FBP1 (0.59) | FBP1P2RY2P2RY4P2RY14MACROD2 | |
| SCHEMBL17581993 | 0.97 | FBP1 (0.59) | FBP1P2RY2P2RY4P2RY14MACROD2 | |
| SCHEMBL5059685 | 0.95 | FBP1 (0.58) | FBP1P2RY2P2RY4P2RY14MACROD2 | |
| SCHEMBL5063577 | 0.95 | FBP1 (0.58) | FBP1P2RY2P2RY4P2RY14MACROD2 | |
| SCHEMBL24474280 | 0.86 | FBP1 (0.51) | FBP1P2RY2P2RY4P2RY14MACROD2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 14 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-3634385-A1 | METHODS FOR THE PREPARATION OF LIPOSOMES COMPRISING DRUGS | Curinanorx, LLC (US) | 2020-04-15 | — | — | EP | disclosed |
| WO-2018209342-A1 | METHODS FOR THE PREPARATION OF LIPOSOMES COMPRISING DRUGS | CURINANORX, LLC (US) | 2018-11-15 | — | — | WO | disclosed |
| US-20170340563-A1 | Methods for the Preparation of Liposomes Comprising Drugs | CURINANORX, LLC | 2017-11-30 | — | — | US | disclosed |
| US-9655846-B2 | Methods for the preparation of liposomes comprising drugs | JAVERI, Indu (US) | 2017-05-23 | — | — | US | disclosed |
| US-9402812-B2 | Methods for the preparation of liposomes | JAVERI, Indu (US) | 2016-08-02 | — | — | US | disclosed |
| US-20140086983-A1 | METHODS FOR THE PREPARATION OF LIPOSOMES COMPRISING DRUGS | JAVERI, Indu (US) | 2014-03-27 | — | — | US | disclosed |
| US-8591942-B2 | Methods for the preparation of liposomes comprising docetaxel | JAVERI, Indu (US) | 2013-11-26 | — | — | US | disclosed |
| EP-2480208-A1 | METHODS FOR THE PREPARATION OF LIPOSOMES | Javeri, Indu (US) | 2012-08-01 | — | — | EP | disclosed |
| EP-2480209-A1 | METHODS FOR THE PREPARATION OF LIPOSOMES COMPRISING DOCETAXEL | Javeri, Indu (US) | 2012-08-01 | — | — | EP | disclosed |
| WO-2011038068-A1 | METHODS FOR THE PREPARATION OF LIPOSOMES | FORMATECH, INC. (US) | 2011-03-31 | — | — | WO | disclosed |
| WO-2011038073-A1 | METHODS FOR THE PREPARATION OF LIPOSOMES COMPRISING DOCETAXEL | FORMATECH, INC. (US) | 2011-03-31 | — | — | WO | disclosed |
| US-20110070295-A1 | METHODS FOR THE PREPARATION OF LIPOSOMES COMPRISING DOCETAXEL | JAVERI, INDU | 2011-03-24 | — | — | US | disclosed |
| US-20110070293-A1 | Methods for the Preparation of Liposomes Comprising Docetaxel | JAVERI, INDU | 2011-03-24 | — | — | US | disclosed |
| US-20110070294-A1 | Methods for the Administration of Drugs Using Liposomes | JAVERI, INDU | 2011-03-24 | — | — | US | disclosed |